Showing posts with label
Blackrock
.
Show all posts
Showing posts with label
Blackrock
.
Show all posts
Friday, June 27, 2025
When the tech "hits the fan" so to speak, who might bid for Cabaletta Bio and their cutting edge technology?
›
Cabaletta Bio is a compelling acquisition target in a growing niche— cell therapy for autoimmune diseases . Its unique platform, strong e...
Thursday, July 25, 2024
Here's why institutional investors are investing in AEVA Technologies at this time and who currently owns the stock!
›
Institutional investors are showing interest in Aeva Technologies (AEVA) for several reasons: Innovative Technology : Aeva is known for its ...
Sunday, July 7, 2024
Editas Medicine $EDIT has pioneered the use of CRISPR technology to develop innovative genomic medicines, potentially transforming the treatment of a wide range of genetic diseases
›
Editas Medicine is a viable player in the biotech field due to several factors: Technological Advancements : Editas focuses on CRISPR-Ca...
›
Home
View web version
